Filter announcements
Loading...
Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services
Bal Pharma announces Mr. Shreepada ML has commenced duties as Company Secretary and Compliance Officer, taking charge as a Key Managerial Personnel. This strengthens the company's corporate governance.
Bal Pharma Limited urges shareholders with physical shares to update KYC details like PAN, bank info, and contact through multiple submission options to ensure smooth dividend credit and future electronic payments. No operational or financial impact reported.
Bal Pharma Limited has withdrawn its application for the reclassification of promoter Ms. Anita Chandraprakash Siroya. This decision comes after discussions with the listing compliance teams of BSE and NSE, considering that she holds more than 10% of the voting rights in the company, which is governed by Regulation 31A...
Bal Pharma has withdrawn its application for the reclassification of promoters Mr. Shrenik D. Siroya and Ms. Jivi Dheerajmal Siroya, as they hold more than 10% of the voting rights in the company, per SEBI regulations. This decision may help maintain stability in the company's governance structure, ensuring that key...
**Updates:** Bal Pharma Limited has resubmitted its unaudited financial results for the quarter ended December 31, 2024. Revenue from operations for the quarter stood at ₹7,288.52 Cr, a decrease from ₹8,149.46 Cr during the same quarter last year. Total income for the period was ₹7,370.49 Cr, reflecting a decline compared...